M Hux

435 total citations
10 papers, 355 citations indexed

About

M Hux is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, M Hux has authored 10 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 3 papers in Economics and Econometrics and 2 papers in Pharmacology. Recurrent topics in M Hux's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Treatment of Major Depression (2 papers) and Bipolar Disorder and Treatment (2 papers). M Hux is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Treatment of Major Depression (2 papers) and Bipolar Disorder and Treatment (2 papers). M Hux collaborates with scholars based in Canada, United Kingdom and Ireland. M Hux's co-authors include Michaël Iskedjian, Serge Gauthier, B O’Brien, Michelle M. Gagnon, Ron Goeree, Paul Grof, M. Arató, Eva Grof, A. W. Clare and Shaunagh O’Sullivan and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Psychiatry and Stroke.

In The Last Decade

M Hux

10 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Hux Canada	7	200	84	83	63	46	10	355
Warachal Faison United States	8	102 0.5×	59 0.7×	78 0.9×	20 0.3×	20 0.4×	16	290
Linda Hewett United States	6	197 1.0×	30 0.4×	68 0.8×	26 0.4×	51 1.1×	8	350
Dominique Milea France	13	163 0.8×	42 0.5×	92 1.1×	39 0.6×	178 3.9×	32	522
Byeong Kil Yeon South Korea	8	219 1.1×	31 0.4×	74 0.9×	28 0.4×	43 0.9×	10	357
Franziska Tebarth Germany	9	289 1.4×	51 0.6×	132 1.6×	43 0.7×	9 0.2×	9	473
Michael J. Tueth United States	13	135 0.7×	23 0.3×	56 0.7×	62 1.0×	37 0.8×	31	454
J.M. Hegeman Netherlands	9	127 0.6×	18 0.2×	52 0.6×	26 0.4×	62 1.3×	11	412
Tatiana Sadak United States	13	232 1.2×	19 0.2×	171 2.1×	56 0.9×	30 0.7×	38	505
Toru Okura United States	5	326 1.6×	20 0.2×	110 1.3×	35 0.6×	26 0.6×	8	453
Paul Calloway United Kingdom	6	351 1.8×	48 0.6×	82 1.0×	21 0.3×	10 0.2×	7	515

Countries citing papers authored by M Hux

Since Specialization

Citations

This map shows the geographic impact of M Hux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hux more than expected).

Fields of papers citing papers by M Hux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hux. The network helps show where M Hux may publish in the future.

Co-authorship network of co-authors of M Hux

This figure shows the co-authorship network connecting the top 25 collaborators of M Hux. A scholar is included among the top collaborators of M Hux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hux. M Hux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Hux, M, et al.. (2022). Research on Acupoint Tapping Therapies Proliferating around the World. 14(1). 22–37. 2 indexed citations

2.

Belovich, Doris, et al.. (2009). Cost-effectiveness of capecitabine in combination with oxaliplatin (XELOX) compared with FOLFOX for the treatment of metastatic colorectal cancer: A Canadian evaluation. Journal of Clinical Oncology. 27(15_suppl). e17502–e17502. 1 indexed citations

3.

Rundek, Tatjana, Kirsten Vang Nielsen, Stephen Phillips, et al.. (2004). Health Care Resource Use After Acute Stroke in the Glycine Antagonist in Neuroprotection (GAIN) Americas Trial. Stroke. 35(6). 1368–1374. 12 indexed citations

4.

Feldman, Howard, Serge Gauthier, Jane Hecker, et al.. (2004). P1-386 Pharmacoeconomic benefits of donepezil treatment in severe Alzheimer's disease. Neurobiology of Aging. 25. S208–S208. 3 indexed citations

5.

Hux, M, B O’Brien, Michaël Iskedjian, et al.. (1998). Relation between severity of Alzheimer's disease and costs of caring.. PubMed. 159(5). 457–65. 193 indexed citations

6.

Iskedjian, Michaël, M Hux, & Gary Remington. (1998). The Canadian experience with risperidone for the treatment of schizophrenia: an overview.. PubMed. 23(4). 229–39. 8 indexed citations

7.

Miller, J. Philip, Shaunagh O’Sullivan, Veronica Fitzpatrick, et al.. (1988). A Follow-up Study on Alcoholics with and without Co-existing Affective Disorder. The British Journal of Psychiatry. 152(6). 813–819. 64 indexed citations

8.

Grof, Paul, et al.. (1987). Methylene blue: a reliable and practical marker for validating compliance on the DST.. PubMed. 48(6). 224–9. 6 indexed citations

9.

Hux, M, et al.. (1987). Psychotropic drug withdrawal and the dexamethasone suppression test. American Journal of Psychiatry. 144(1). 82–85. 28 indexed citations

10.

Grof, Paul, M Hux, Eva Grof, & M. Arató. (1983). Prediction of Response to Stabilizing Lithium Treatment. Pharmacopsychiatry. 16(6). 195–200. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact